摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(m-chlorophenoxy)-3-(n-propyl)-2,3,4,5-tetrahydro-3-benzazepine | 89739-09-3

中文名称
——
中文别名
——
英文名称
1-(m-chlorophenoxy)-3-(n-propyl)-2,3,4,5-tetrahydro-3-benzazepine
英文别名
1-(3-Chlorophenoxy)-3-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine;5-(3-chlorophenoxy)-3-propyl-1,2,4,5-tetrahydro-3-benzazepine
1-(m-chlorophenoxy)-3-(n-propyl)-2,3,4,5-tetrahydro-3-benzazepine化学式
CAS
89739-09-3
化学式
C19H22ClNO
mdl
——
分子量
315.843
InChiKey
DVOIXRDUSKIDOS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines
    摘要:
    该发明涉及式中Y为相同或不同的氢和较低的烷氧基;X为氢、卤素、较低的烷基、较低的烷氧基、三氟甲基、硝基、氰基和氨基;R为氢、较低的烷基、环烷基较低的烷基、Ar较低的烷基;其中Z为氢、较低的烷基、较低的烷氧基、卤素、三氟甲基、硝基和氨基;Aryloxy较低的烷基;以及药学上可接受的酸盐。
    公开号:
    US04794181A1
点击查看最新优质反应信息

文献信息

  • Medical compositions of 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04935418A1
    公开(公告)日:1990-06-19
    The invention relates to 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines of the formula ##STR1## wherein Y is the same or different and is hydrogen and lower alkoxy; X is hydrogen, halogen, lower alkyl, lower alkoxy, CF.sub.3, NO.sub.2, CN and NH.sub.2 ; R is hydrogen, lower alkyl, cycloalkyllower alkyl, ##STR2## Ar lower alkyl of the formula ##STR3## where Z is hydrogen, lower alkyl, lower alkoxy, halogen CF.sub.3, NO.sub.2 and NH.sub.2 ; Aryloxy lower alkyl of the formula ##STR4## where Z is as previously defined; and an alkylene amine of the formula ##STR5## where R.sub.1 and R.sub.2 are the same or different and are hydrogen and lower alkyl, n is an integer of 1 or 2; and the pharmaceutically acceptable acid addition salts thereof.
    本发明涉及式子##STR1##中的1-芳氧基-2,3,4,5-四氢-3-苯并哌啶;其中Y相同或不同,是氢和低级烷氧基;X是氢、卤素、低级烷基、低级烷氧基、CF.sub.3、NO.sub.2、CN和NH.sub.2;R是氢、低级烷基、环烷基低级烷基、##STR2## Ar低级烷基的式子##STR3##其中Z是氢、低级烷基、低级烷氧基、卤素CF.sub.3、NO.sub.2和NH.sub.2;芳氧基低级烷基的式子##STR4##其中Z如前所述;以及式子##STR5##中的烷基胺,其中R.sub.1和R.sub.2相同或不同,是氢和低级烷基,n是1或2的整数;以及其药学上可接受的酸盐。
  • 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04988690A1
    公开(公告)日:1991-01-29
    The invention relates to 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines of the formula ##STR1## wherein Y is the same or different and is hydrogen and lower alkoxy; X is hydrogen, halogen, lower alkyl, lower alkoxy, CF.sub.3, NO.sub.2, CN and NH.sub.2 ; R is hydrogen, lower alkyl, cycloalkyllower alkyl, ##STR2## Ar lower alkyl of the formula -alkylene ##STR3## where Z is hydrogen, lower alkyl, lower alkoxy, halogen, CF.sub.3, NO.sub.2 and NH.sub.2 ; and an alkylene amine of the formula ##STR4## where R.sub.1 and R.sub.2 are the same of different and are hydrogen and lower alkyl, and the pharmaceutically acceptable acid addition salts thereof.
    本发明涉及式为##STR1##的1-芳氧基-2,3,4,5-四氢-3-苯并哌啶,其中Y相同或不同,为氢和较低的烷氧基;X为氢、卤素、较低的烷基、较低的烷氧基、CF.sub.3、NO.sub.2、CN和NH.sub.2;R为氢、较低的烷基、环烷基较低的烷基、##STR2##Ar为-烷基-##STR3##的较低烷基,其中Z为氢、较低的烷基、较低的烷氧基、卤素、CF.sub.3、NO.sub.2和NH.sub.2;以及式为##STR4##的烷基胺和其药学上可接受的酸盐。
  • 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine preparation
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US05059688A1
    公开(公告)日:1991-10-22
    The invention relates to 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines of the formula ##STR1## wherein Y is the same or different and is hydrogen and lower alkoxy; X is hydrogen, halogen, lower alkyl, lower alkoxy, CF.sub.3, No.sub.2, CN and NH.sub.2 ; R is hydrogen, lower alkyl, cycloalkyllower alkyl, ##STR2## Ar lower alkyl of the formula ##STR3## where Z is hydrogen, lower alkyl, lower alkoxy, halogen CF.sub.3, NO.sub.2 and NH.sub.2 ; Aryloxy lower alkyl of the formula ##STR4## where Z is as previously defined; and an alkylene amine of the formula ##STR5## where R.sub.1 and R.sub.2 are the same or different and are hydrogen and lower alkyl, n is an integer of 1 or 2; and the pharmaceutically acceptable acid addition salts thereof.
    本发明涉及公式## STR1的1-芳氧基-2,3,4,5-四氢-3-苯并氮平,其中Y相同或不同,为氢和低级烷氧基; X为氢,卤素,低级烷基,低级烷氧基,CF.sub.3,No.sub.2,CN和NH.sub.2; R为氢,低级烷基,环烷基低级烷基,## STR2的公式,Ar为## STR3的公式的芳基低级烷基,其中Z为氢,低级烷基,低级烷氧基,卤素CF.sub.3,NO.sub.2和NH.sub.2;芳氧基低级烷基的公式## STR4,其中Z如前所述;以及公式## STR5的烷基胺,其中R.sub.1和R.sub.2相同或不同,为氢和低级烷基,n为1或2;和其药学上可接受的酸加盐。
  • 1-Aryloxy-2,3,4,5-tetrahydro-3-benzazepines, a process for preparing the same and their use as medicaments
    申请人:HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED
    公开号:EP0096838A1
    公开(公告)日:1983-12-28
    The invention relates to 1-aryloxy-2,3,4,5-tetrahydro-3- benzazepines of the formula wherein Y, and Y2 are the same or different and are hydrogen or lower alkoxy; X is hydrogen, halogen, lower alkyl, lower alkoxy, CF3, NO2, CN and NH2; R is hydrogen, lower alkyl, cycloatkyllower alkyl Ar lower alkyl of the formula -alkylene where Z is hydrogen, lower alkyl, lower alkoxy, halogen, CF3, NO2; and NH2; and an alkylene amine of the formula -alkylene where R, and R2 are the same or different and are hydrogen and lower alkyl and the alkylene moiety is of 1 to 6 carbon atoms, and the pharmaceutically acceptable acid addition salts thereof.
    本发明涉及 1-芳氧基-2,3,4,5-四氢-3-苯并氮杂卓,其式为 其中 Y 和 Y2 是相同或不同的,并且是氢或低级烷氧基;X 是氢、卤素、低级烷基、低级烷氧基、CF3、NO2、CN 和 NH2;R 是氢、低级烷基、环烷基低级烷基 Ar 式中的低级烷基-亚烷基 其中 Z 是氢、低级烷基、低级烷氧基、卤素、CF3、NO2 和 NH2;以及式 - 烷基胺 其中 R 和 R2 相同或不同,且为氢和低级烷基,亚烷基为 1 至 6 个碳原子,以及它们的药学上可接受的酸加成盐。
  • US4794181A
    申请人:——
    公开号:US4794181A
    公开(公告)日:1988-12-27
查看更多